# Evaluating Respiratory Symptoms in Chronic Obstructive Pulmonary Disease, a Patient-Reported Outcome Instrument for the Measurement of Severity of Respiratory Symptoms in Stable Chronic Obstructive Pulmonary Disease: Qualification for Exploratory Use - FDA Guidance Document

Source: https://www.globalkeysolutions.net/guidances/guidance-document/evaluating-respiratory-symptoms-in-chronic-obstructive-pulmonary-disease-a-patient-reported-outcome-instrument-for-the-measurement-of-severity-of-respiratory-symptoms-in-stable-chronic-obstructive-pulmonary-disease-qualification-for-exploratory-use/a00af674-c3a1-4cdf-b25f-1b529c175262

> FDA guidance document: Evaluating Respiratory Symptoms in Chronic Obstructive Pulmonary Disease, a Patient-Reported Outcome Instrument for the Measurement of Severity of Respiratory Symptoms in Stable Chronic Obstructive Pulmonary Disease: Qualification for Exploratory Use. Issue date: March 01, 2016. Get complete insights and analysis.

---

## Details

- Title: Evaluating Respiratory Symptoms in Chronic Obstructive Pulmonary Disease, a Patient-Reported Outcome Instrument for the Measurement of Severity of Respiratory Symptoms in Stable Chronic Obstructive Pulmonary Disease: Qualification for Exploratory Use
- Communication Type: Guidance Document
- Product Type: drugs
- Office Name: Center for Drug Evaluation and Research
- Office URL: /offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c
- Issue Date: 2016-03-01
- Last Changed: 2019-06-15

## Related Documents

- [Drug Interaction Information in Human Prescription Drug and Biological Product Labeling](https://www.globalkeysolutions.net/guidances/guidance-document/drug-interaction-information-in-human-prescription-drug-and-biological-product-labeling/8bdf2914-581b-4e86-8a13-dacb0ef306c0)
- [Early Alzheimer’s Disease: Developing Drugs for Treatment](https://www.globalkeysolutions.net/guidances/guidance-document/early-alzheimers-disease-developing-drugs-for-treatment/ef0ff9a7-7208-4951-acbb-acb9937f83e7)
- [Attachement - Qualification Process for Drug Development Tools: Qualification of Exacerbations of Chronic Pulmonary Disease Tool for Measurement of Symptoms of Acute Bacterial Exacerbation of Chronic Bronchitis in Patients With Chronic Obstructive Pulmonary Disease](https://www.globalkeysolutions.net/guidances/guidance-document/attachement-qualification-process-for-drug-development-tools-qualification-of-exacerbations-of-chronic-pulmonary-disease-tool-for-measurement-of-symptoms-of-acute-bacterial-exacerbation-of-chronic-bronchitis-in-patients-with-chronic-obstructive-pulmonary-disease/88815054-17fc-4e46-a5c1-be7b0bad1ea9)